MS Financial Statements & Analysis
Complete financial statements for MS including income statement, balance sheet, and cash flow statement. Analyze MS's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
77
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
16.8% ↑
Net Income
47.4% ↑
Gross Margin
-2.1% ↓
Operating Margin
27.5% ↑
Balance Sheet
Current Ratio
-9.0% ↓
Debt to Equity
0.8% ↓
Asset Turnover
14.8% ↑
Cash Flow
Operating Cash Flow
104.1% ↑
Net Cash Flow
141.5% ↑
Free Cash Flow
94.3% ↑
Cash Flow to Debt
103.8% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
Metric | 2023 | 2024 | Change | Impact |
---|---|---|---|---|
Revenue | 88.29B | 103.14B | 16.8% | |
Gross Profit | 50.13B | 57.36B | 14.4% | |
Operating Income | 11.81B | 17.60B | 49.0% | |
Net Income | 9.09B | 13.39B | 47.4% | |
EPS | 5.24 | 8.04 | 53.4% | |
EBITDA | 16.07B | 22.76B | 41.6% | |
Gross Margin | 56.79% | 55.61% | 2.1% | |
Operating Margin | 13.38% | 17.06% | 27.5% | |
Net Income Margin | 10.29% | 12.98% | 26.1% | |
R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 103.14B | 88.29B | 62.48B | 57.78B | 45.83B |
Gross Profit | 57.36B | 50.13B | 49.93B | 56.41B | 45.83B |
Operating Income | 17.60B | 11.81B | 14.09B | 19.67B | 0 |
Net Income | 13.39B | 9.09B | 11.03B | 15.03B | 11.00B |
EPS | 8.04 | 5.24 | 6.23 | 8.16 | 6.55 |
EBITDA | 22.76B | 16.07B | 18.09B | 23.88B | 0 |
Gross Margin | 55.61% | 56.79% | 79.92% | 97.63% | 100.00% |
Operating Margin | 17.06% | 13.38% | 22.55% | 34.04% | 0.00% |
Net Income Margin | 12.98% | 10.29% | 17.65% | 26.02% | 23.99% |
R&D Expenses | 0 | 0 | 0 | 0 | 0 |